Related Experiment Video
Updated: Aug 17, 2025

Manipulation of Epileptiform Electrocorticograms ECoGs and Sleep in Rats and Mice by Acupuncture
Published on: December 22, 2016
Effect of valproate on sleep patterns disturbed by epilepsy
Fructuoso Ayala-Guerrero1, Daniel Castro-Domínguez1, Erik L Mateos-Salgado1
1Facultad de Psicología, Universidad Nacional Autónoma de México, México.
Valproate, an epilepsy treatment, was studied in rats. Results show it reduces seizures and increases sleep, suggesting hypnotic properties beyond its antiepileptic effects.
Area of Science:
- Neuroscience
- Pharmacology
- Sleep Medicine
Background:
- Nocturnal epilepsy significantly impacts sleep quality and patient life.
- Experimental animal models are crucial for assessing epilepsy treatments.
- Valproate is a medication used to manage epilepsy symptoms.
Purpose of the Study:
- To investigate the effects of valproate on epilepsy-induced sleep pattern alterations.
- To assess valproate's efficacy in mitigating seizure activity and its impact on sleep.
Main Methods:
- Wistar rats with chronic implants were used to record sleep patterns over three days.
- Animals were divided into control and experimental groups.
- Seizures were induced using pentylenetetrazol (PTZ), with one group receiving valproate pretreatment.
Main Results:
- Valproate demonstrated significant antiepileptic effects.
- Valproate administration led to an increase in sleep occurrence.
- The drug appears to enhance GABAergic mechanisms, reducing seizure severity.
Conclusions:
- Valproate possesses both antiepileptic and hypnotic properties.
- It effectively mitigates PTZ-induced seizures in rats.
- Valproate's action on GABAergic systems contributes to seizure control and increased sleep.
Related Concept Videos
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic Drugs: Sodium Channel Blockers
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...

